HomeSDGR • NASDAQ
Schrodinger Inc
$18.74
After Hours:
$18.85
(0.59%)+0.11
Closed: Sep 27, 6:54:58 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$18.92
Day range
$18.62 - $19.42
Year range
$18.02 - $38.00
Market cap
1.36B USD
Avg Volume
560.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Jun 2024Y/Y change
Revenue
47.33M34.51%
Operating expense
84.06M12.17%
Net income
-54.05M-1,363.37%
Net profit margin
-114.18-1,038.98%
Earnings per share
-0.74-23.35%
EBITDA
-51.33M14.41%
Effective tax rate
-0.15%
Total assets
Total liabilities
(USD)Jun 2024Y/Y change
Cash and short-term investments
377.29M-31.24%
Total assets
688.37M-18.20%
Total liabilities
214.39M-6.92%
Total equity
473.98M
Shares outstanding
72.80M
Price to book
2.91
Return on assets
-18.49%
Return on capital
-21.30%
Net change in cash
(USD)Jun 2024Y/Y change
Net income
-54.05M-1,363.37%
Cash from operations
-53.72M-191.29%
Cash from investing
29.58M-56.01%
Cash from financing
1.61M-64.48%
Net change in cash
-22.54M-142.27%
Free cash flow
-35.65M-161.07%
About
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. Schrödinger's software is used by pharmaceutical companies, biotech firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market. Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
Founded
1990
Employees
867
Search
Clear search
Close search
Google apps
Main menu